An Alternative Method for Preventing Extravasation Complications in Vascular Access Catheters with Reservoirs for Subcutaneous Infusion: THE Double Injection Technique
Restricted accessResearch articleFirst published online September, 2002
An Alternative Method for Preventing Extravasation Complications in Vascular Access Catheters with Reservoirs for Subcutaneous Infusion: THE Double Injection Technique
Long-term intravascular access catheters with reservoirs are a common requirement for cancer patients. Complications resulting from the use of these devices have been studied in several single-institution investigations, the consensus being that they are safe and have a low complication rate. However, extravasation may occur especially in obese patients due to accidental infusion of the subcutaneous tissue. To prevent this problem we describe an easy method that could be an alternative to the widely used ultrasonography-guided injection method.
SmittP.S.TsafkaA.Teng-van de ZandeF.Van der HoltR.Elswijk-de VriesI.ElfrinkE.Van den BentM.J.VechtC.J.: Outcome and complications of epidural analgesia in patients with chronic cancer pain.Cancer, 83: 2015–2022, 1998.
2.
GrossoM.ZanonC.ZanonE.CorsicoM.GazzeraC.ManciniA.FavaC.: The percutaneous placement of intra-arterial catheters with “reservoirs” for subcutaneous infusion. The technic and preliminary results.Radiol Med, 94: 226–232, 1997.
3.
AldrighettiL.CateriniR.RonzoniM.JannelloA.FerlaG.: Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient.Minerva Chir, 50: 447–454, 1995.
4.
BrownD.F.MuirheadM.J.TravisP.M.VireS.R.JensenM.: Mode of chemotherapy does not affect complications with an implantable venous access device.Cancer, 80: 966–972, 1997.
5.
WesenbergF.FlaattenH.JanssenC.W.: Central venous catheter with subcutaneous injection port (Port-A-Cath): 8 years clinical follow up with children.Pediatr Hematol Oncol, 10: 233–239, 1993.
6.
SchwarzR.E.GroegerJ.S.CoitD.G.: Subcutaneously implanted central venous access device in cancer patients: a prospective analysis.Cancer, 79: 1635–1640, 1997.
7.
YazigiA.YazbeckP.Bou-SabaR.AntaklyM.C.: Complications and outcome of implantable infusion pumps: a propos of 60 cases.Ann Fr Anesth Reanim, 13: 297–300, 1994.
8.
KincaidE.H.DavisP.W.ChangM.C.FenstermarkerJ.M.PennellT.C.: “Blind” placement of long-term central venous access device: report of 589 consecutive procedures.Am Surg, 65: 520–523, 1999.
9.
StreckerE.P.K.Ostheim-DzerowyczW.BoosI.B.L.: Intraarterial infusion therapy via a subcutaneous port for limb-threatening ischemia: a pilot study.Cardiovasc Intervent Radiol, 21: 109–115, 1998.
10.
BarriosC.H.ZucheJ.H.BlaesB.HirschJ.D.LyssA.B.: Evaluation of an implantable venous access system in a general oncology population.Oncology, 49: 474–478, 1992.
11.
TorramadeJ.R.CienfuegosJ.A.HernandezJ.L.PardoF.BenitoC.GonzalesJ.BalenE.De VillaV.: The complications of central venous access systems: a study of 218 patients.Eur J Surg, 159: 323–327, 1993.
12.
GrannanK.J.TaylorP.H.: Early and late complications of totally implantable venous access devices.J Surg Oncol, 44: 52–54, 1990.
13.
WilsonJ.CarderP.GooiJ.NishikawaH.: Recall phenomenon following epirubicin.Clin Oncol R Coll Radiol, 11: 424–425, 1999.
14.
GroegerJ.S.LucasA.B.ThalerH.T.Friedlander-KlarH.BrownaeA.E.KiehnT.E.ArmstrongD.: Infectious morbidity associated with long-term use of venous access devices in patients with cancer.Ann Intern Med, 119: 1168–1174, 1993.
15.
EastridgeB.J.LeforA.T.: Complications of indwelling venous access devices in cancer patients.J Clin Oncol, 13: 233–238, 1995.
16.
HeitmannC.DurmusC.IngianniG.: Surgical management after doxorubicin and epirubicin extravasation.J Hand Surg, 23: 666–668, 1998.
